Collegium Pharmaceutical financial statements

콜레지움 파머슈티컬NASDAQ:COLL · Nasdaq · Healthcare · sector #17
$21.88+0.05%
2026-10-06 close

Collegium Pharmaceutical's published financial data is dated 2026-10-04. 2024 revenue was $631M. 2024 operating profit was $159M.

Reported results

Collegium Pharmaceutical notifications

Quantus Signal · live data · not investment advice · Privacy Policy